Recent posts

TypeTitleAuthorRepliesLast updated
Reference.Cellular immune suppression in cancer patients and its implication for dendritic cell therapy. Sub-category: Cell-Based Therapy Mikael Nordfors011 years 6 months ago
Reference.Bioavailability of sorafenib tablets administered as a liquid suspension. Mikael Nordfors011 years 6 months ago
Reference.Phase II trial of pharmacodynamically (PDally)-guided optimal biologic dose titration (OBDT) of sorafenib (S) in combination wit Mikael Nordfors011 years 6 months ago
Reference.A phase II trial of thalidomide plus tegafur/uracil for patients with advanced/metastatic hepatocellular carcinoma (HCC) Mikael Nordfors011 years 6 months ago
Reference.A phase II study of sorafenib in combination with tegafur/uracil (UFT) for Asian patients with advanced hepatocellular carcinoma Mikael Nordfors011 years 6 months ago
Reference.Outpatient administration of high-dose methotrexate for osteosarcoma treatment in Brazil. Mikael Nordfors011 years 6 months ago
Reference.Hypoxia-inducible factor-1alpha modulation in combination with anti-angiogenic therapy. Mikael Nordfors011 years 6 months ago
Reference.Control of cancer-associated inflammation and survival: Results from a prospective randomized phase II trial in gastric cancer. Mikael Nordfors011 years 6 months ago
Reference.Oral metronomic chemotherapy using cyclophosphamide in metastatic patients (pts) after standard treatment: Results of a randomiz Mikael Nordfors011 years 6 months ago
Reference.A phase I study of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer. Mikael Nordfors011 years 6 months ago
Reference. Durable responses with the antiangiogenic metronomic regimen RT-PEPC in elderly patients with recurrent mantle cell lymphoma Mikael Nordfors011 years 6 months ago
Reference.A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung Mikael Nordfors011 years 6 months ago
Reference.A novel metronomic schedule of oral vinorelbine for the treatment of metastatic breast cancer in elderly patients............... Mikael Nordfors011 years 6 months ago
Reference.Metronomic schedule of temozolomide with conventional dose of cisplatin in metastatic melanoma. Sub-category: Melanoma Categor Mikael Nordfors011 years 6 months ago
Reference.Effect of metronomic use of zoledronic acid (ZOL) on antitumor and antiosteoclastic effects in breast cancer patients with bone Mikael Nordfors011 years 6 months ago
Reference.Low-dose methotrexate and cyclophosphamide in recurrent ovarian cancer. Mikael Nordfors011 years 6 months ago
Reference.Phase II study of docetaxel-prednisone (DP) in combination with metronomic cyclophosphamide (CTX) and celecoxib (C) ...... Mikael Nordfors011 years 6 months ago
Reference.CECs, CEPs and CTCs for prediction of response in patients with advanced breast cancer (ABC) receiving metronomic vinorelbine. Mikael Nordfors011 years 6 months ago
Reference.Activity of a multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen in metastatic renal cell carcinoma (m Mikael Nordfors011 years 6 months ago
Reference.Preclinical antitumor and antiangiogenic activity of a metronomic schedule of cisplatin against human transitional cell carcinom Mikael Nordfors011 years 6 months ago
Reference.Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer with metronomic UFT + CP Mikael Nordfors011 years 6 months ago
ArgumentAn extremely interesting study! Mikael Nordfors011 years 6 months ago
Reference.Combining agents that target the tumor microenvironment improves the efficacy of anticancer therapy. Mikael Nordfors011 years 6 months ago
Reference.A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses Mikael Nordfors011 years 6 months ago
Reference.Combination antiangiogenic therapy: increased efficacy in a murine model of Wilms tumor. Mikael Nordfors011 years 6 months ago

Pages